Friday, July 6, 2012

Long-term effect of trastuzumab on QT dispersion in adjuvant treatment for patients with Her2 receptor positive breast cancer: a pilot study.

Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort.

Gianni L, Eiermann W, Semiglazov V, Manikhas A, Lluch A, Tjulandin S, Zambetti M, Vazquez F, Byakhow M, Lichinitser M, et al. Lancet. 2010 Jan 30; 375(9712):377-84.

Source: http://www.ncbi.nlm.nih.gov/PubMed/22752572?dopt=Abstract

drew peterson florida gop debate freddie mac kristin cavallari jay cutler oscar nominations rough riders

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.